Clinical trials
Observational Urinary Bladder Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Photocure | 2 |
| AHS Cancer Control Alberta | 1 |
| AstraZeneca | 1 |
| Baylor College of Medicine | 1 |
| Bernie Eigl | 1 |
| Cepheid | 1 |
| London Health Sciences Centre | 1 |
| Pfizer | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 16 |
| Carcinoma, Transitional Cell | 4 |
| Lung Neoplasms | 3 |
| Pancreatic Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Small Cell | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.